CSL Limited (CMXHF)
OTCMKTS · Delayed Price · Currency is USD
130.02
-4.98 (-3.69%)
Sep 14, 2025, 8:00 PM EDT

CSL Limited Company Description

CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants.

This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.

The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments.

The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology.

It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

CSL Limited
CSL Limited logo
CountryAustralia
Founded1916
IndustryBiotechnology
SectorHealthcare
Employees29,904
CEOPaul McKenzie

Contact Details

Address:
655 Elizabeth Street
Melbourne, 3000
Australia
Phone61 3 9389 1911
Websitecsl.com

Stock Details

Ticker SymbolCMXHF
ExchangeOTCMKTS
Fiscal YearJuly - June
Reporting CurrencyUSD
ISIN NumberAU000000CSL8
SIC Code2836

Key Executives

NamePosition
Dr. Paul F. McKenzie Ph.D.MD, Chief Executive Officer and Executive Director
Joy Carolyn Linton B.Com., BComm, GAICD, Grad Dip AFIChief Financial Officer
Andy SchmeltzExecutive Vice President of CSL Behring
Dr. Mary Oates Ph.D.Chief Operating Officer
Chris CooperHead of Investor Relations
Gregory Boss B.S., BS(Hons), J.D.Executive Vice President of Legal and General Counsel
Roanne ParryChief Human Resources Officer
Dr. William Mezzanotte M.D., M.P.H.Chief Medical Officer, Executive Vice President and Head of Research and Development
Mark Hill B.A., M.B.A.Chief Digital Information Officer and Executive Vice President
Deirdre BeVardSenior Vice President of Research and Development Strategic Operations